Literature DB >> 35121428

Fabrication of hexagonal boron carbonitride nanoplates using for in vitro photodynamic therapy and chemo therapy.

Huan Yang1, Jiaxin Li2, Shuidan Gu2, Zhiyu Wu3, Lijie Luo4, Yongjun Chen5.   

Abstract

Carbon nanomaterials and boron nitride nanomaterials have been proved to be very potential for biomedical applications. However, as an analog of them, boron carbonitride nanomaterials are rarely reported in biomedical field. In this study, the fabrication of visible light-responsive boron carbonitride nanoplates (BCNNPs) and their application in photodynamic therapy and chemo therapy were demonstrated. BCNNPs with an average size of 46 nm were fabricated via hydrogen peroxide treatment from bulk BCN. Cytotoxicity tests showed that the as-prepared BCNNPs are biocompatible and have no cytotoxicity to human breast cancer cells and human hepatocyte carcinoma cells. After conjunction with doxorubicin and folic acid, the BCNNPs were adopted as a targeted drug carrier, presenting pH-responsive release and tumor-targeting property for chemo therapy. Moreover, under certain intensity of visible light irradiation (45 mW/cm2), the BCNNPs can generate reactive oxygen species including superoxide radical, hydroxyl radical and singlet oxygen, so that synergistic photodynamic/chemo therapy effects were achieved. This work may be a groundbreaking discovery for utilizing BCNNPs as photosensitizer for photodynamic therapy and drug carrier for chemo therapy.
Copyright © 2022 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Boron carbonitride nanoplates; Chemo therapy; Fabrication; In vitro; Photodynamic therapy

Mesh:

Substances:

Year:  2022        PMID: 35121428     DOI: 10.1016/j.colsurfb.2022.112377

Source DB:  PubMed          Journal:  Colloids Surf B Biointerfaces        ISSN: 0927-7765            Impact factor:   5.268


  1 in total

1.  Boron Nitride Nanoparticles Loaded with a Boron-Based Hybrid as a Promising Drug Carrier System for Alzheimer's Disease Treatment.

Authors:  Özge Çağlar Yıldırım; Mehmet Enes Arslan; Sena Öner; Ivana Cacciatore; Antonio Di Stefano; Adil Mardinoglu; Hasan Turkez
Journal:  Int J Mol Sci       Date:  2022-07-26       Impact factor: 6.208

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.